NCT05390944 2025-09-16
An BE Study to Compare 10mg & 20mg of IMP4297 Capsules in Healthy Chinese Subjects Under Fasting Condition
Impact Therapeutics, Inc.
Phase 1 Completed
Clinical Trials
7 trialsNCT05391048 2025-09-16
An BE Study to Compare 10mg & 20mg of IMP4297 Capsules in Healthy Chinese Subjects Under Fed Condition
Impact Therapeutics, Inc.
Phase 1 Completed
NCT07030439 2025-06-22
A Bioequivalence Study to Compare Senaparib Manufactured at 2 Sites in Healthy Subjects in Fasting State
Impact Therapeutics, Inc.
Phase 1 Completed
NCT07019194 2025-06-13
An Bioequivalence Study to Compare 10mg & 20mg of Senaparib Capsules in Healthy Chinese Subjects Under Fasting Condition
Impact Therapeutics, Inc.
Phase 1 Completed
NCT04351165 2021-08-24
BA Study of IMP4297 (20mg vs 10mg) in Healthy Male Subjects
Impact Therapeutics, Inc.
Phase 1 Completed
NCT04584515 2021-08-24
IMP4297 DDI (Drug-Drug Interaction)Trial in Healthy Male Volunteers
Impact Therapeutics, Inc.
Phase 1 Completed
NCT04057729 2020-03-30
IMP4297 Food Effect Trial in Healthy Volunteers
Impact Therapeutics, Inc.
Phase 1 Completed